Genmab | GEN - Trade Debtors

Stock Price
1,695.00
Daily Change
11.00 0.65%
Monthly
-4.51%
Yearly
28.41%
Q2 Forecast
1,604.35

Genmab reported DKK1.17B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Almirall EUR 175.93M 17.87M Dec/2025
Amarin USD 126.83M 477K Dec/2025
Amgen USD 9.14B 432M Mar/2026
argenx SE USD 1.66B 458.83M Dec/2025
AstraZeneca USD 17.88B 1.17B Mar/2026
Bayer EUR 18.55B 4.36B Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Demant DKK 5.5B 262M Dec/2025
Exelixis USD 328.95M 42.03M Mar/2026
Fresenius Medical Care EUR 3.72B 58.09M Mar/2026
Genmab DKK 1.17B 119M Dec/2025
GlaxoSmithKline GBP 7.94B 178M Mar/2026
GN Store Nord DKK 2.44B 2.86B Mar/2026
GRIFOLS EUR 958M 106M Mar/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Insmed USD 178.55M 37.7M Mar/2026
Lakefront Biotherapeutics EUR 54.03M 145.72M Mar/2026
Lonza CHF 1.78B 55M Dec/2025
Merck EUR 4.44B 293M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026
UCB EUR 1.97B 54M Dec/2025